ecancer
ecancer is a UK charity which provides accessible, high-quality educational content, free to the global oncology community. Our mission is to raise the standards of care for cancer patients across the world through education.
ESMO 2023 Insights: "Alliance A021602 Study - Cabozantinib vs. Placebo for Advanced Neuroendocrine Tumours After Progression on Prior Therapy"
By
ecancer
FEATURING
Jennifer Chan
By
ecancer
FEATURING
Jennifer Chan
Login to view comments.
Click here to Login
